{"id":"plan-b-levonorgestrel","safety":{"commonSideEffects":[{"rate":"20-25","effect":"Nausea"},{"rate":"13-17","effect":"Fatigue"},{"rate":"10-16","effect":"Headache"},{"rate":"11-12","effect":"Dizziness"},{"rate":"5-6","effect":"Vomiting"},{"rate":"5-6","effect":"Abdominal pain"},{"rate":"variable","effect":"Menstrual irregularities"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Levonorgestrel works as an emergency contraceptive by suppressing the luteinizing hormone (LH) surge necessary for ovulation, thereby preventing the release of an egg from the ovary. It may also alter cervical mucus and endometrial conditions to reduce sperm transport and implantation likelihood. When taken within 72 hours of unprotected intercourse, it significantly reduces the risk of pregnancy.","oneSentence":"Levonorgestrel is a synthetic progestin that prevents pregnancy primarily by inhibiting or delaying ovulation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:41.229Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Emergency contraception to prevent pregnancy following unprotected intercourse or contraceptive failure"}]},"trialDetails":[{"nctId":"NCT06273644","phase":"NA","title":"Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment","status":"RECRUITING","sponsor":"Nordlandssykehuset HF","startDate":"2024-01-27","conditions":"Porphyria, Acute Intermittent","enrollment":50},{"nctId":"NCT05172999","phase":"PHASE2, PHASE3","title":"Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia","status":"COMPLETED","sponsor":"Fudan University","startDate":"2022-01-08","conditions":"Atypical Endometrial Hyperplasia, Obesity, Fertility Issues","enrollment":30},{"nctId":"NCT06904274","phase":"PHASE3","title":"Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months","status":"RECRUITING","sponsor":"Bayer","startDate":"2025-11-24","conditions":"Endometrial Hyperplasia","enrollment":207},{"nctId":"NCT07264933","phase":"NA","title":"Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-02-12","conditions":"Scar Niche, Myometrial Remodeling, Contraceptive Device; Complications","enrollment":750},{"nctId":"NCT06134479","phase":"PHASE3","title":"Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-12-12","conditions":"Fertility","enrollment":194},{"nctId":"NCT04684368","phase":"PHASE2","title":"A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2021-07-13","conditions":"Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma","enrollment":160},{"nctId":"NCT07229209","phase":"NA","title":"Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-02-05","conditions":"Abnormal Uterine Bleeding, Cesarean Section Complications, Uterine Scar","enrollment":166},{"nctId":"NCT02397083","phase":"PHASE2","title":"Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-09-23","conditions":"Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma","enrollment":102},{"nctId":"NCT07388511","phase":"PHASE1","title":"A Study of Elenestinib in Healthy Adult Female Participants","status":"RECRUITING","sponsor":"Blueprint Medicines Corporation","startDate":"2026-02-03","conditions":"Healthy Participants","enrollment":20},{"nctId":"NCT05570786","phase":"PHASE2","title":"Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment","status":"COMPLETED","sponsor":"Science Valley Research Institute","startDate":"2023-02-13","conditions":"Deep Endometriosis, Pelvic Pain","enrollment":100},{"nctId":"NCT06883526","phase":"PHASE1, PHASE2","title":"Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma","status":"RECRUITING","sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","startDate":"2025-05-16","conditions":"Lymphoma","enrollment":60},{"nctId":"NCT05916469","phase":"","title":"Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2025-09-24","conditions":"Heavy Menstrual Bleeding, Bleeding Disorder, Von Willebrand Diseases","enrollment":300},{"nctId":"NCT03043924","phase":"NA","title":"Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2017-09-26","conditions":"Polycystic Ovary Syndrome","enrollment":52},{"nctId":"NCT03482986","phase":"NA","title":"Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-12-07","conditions":"Bariatric Surgery, Sleeve Gastrectomy, Obesity","enrollment":44},{"nctId":"NCT03537768","phase":"PHASE4","title":"Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg","status":"TERMINATED","sponsor":"Kimberly Myer","startDate":"2018-07-12","conditions":"Contraception","enrollment":532},{"nctId":"NCT06306131","phase":"PHASE2","title":"Phase II Study of Ovulation in Obese Women","status":"RECRUITING","sponsor":"InnovaGyn, Inc.","startDate":"2023-12-10","conditions":"Pregnancy Prevention","enrollment":22},{"nctId":"NCT05695352","phase":"PHASE2","title":"Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days","status":"RECRUITING","sponsor":"InnovaGyn, Inc.","startDate":"2022-06-28","conditions":"Pregnancy Prevention","enrollment":21},{"nctId":"NCT00788671","phase":"PHASE2","title":"Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2008-11-03","conditions":"Atypical Endometrial Hyperplasia, Stage I Uterine Corpus Cancer AJCC v7, Stage IA Uterine Corpus Cancer AJCC v7","enrollment":69},{"nctId":"NCT05316493","phase":"PHASE2, PHASE3","title":"Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia","status":"RECRUITING","sponsor":"Xiaojun Chen","startDate":"2022-06-13","conditions":"Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity","enrollment":172},{"nctId":"NCT01088178","phase":"NA","title":"Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, Portsmouth","startDate":"2009-11","conditions":"Contraception","enrollment":""},{"nctId":"NCT01161095","phase":"NA","title":"A Multicenter Analysis of Levonorgestrel-Intrauterine System (LNG-IUS) Use in the Postpartum Period","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, Portsmouth","startDate":"2010-07-01","conditions":"Contraception, Postpartum Period","enrollment":""},{"nctId":"NCT06942377","phase":"PHASE2","title":"Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-07-15","conditions":"Endometrial Cancer","enrollment":140},{"nctId":"NCT06073184","phase":"PHASE2","title":"Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-08","conditions":"Endometrial Cancer, Atypical Hyperplasia","enrollment":71},{"nctId":"NCT03673007","phase":"NA","title":"Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Michigan","startDate":"2018-08-26","conditions":"Pregnancy","enrollment":4633},{"nctId":"NCT04371900","phase":"NA","title":"Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2018-08-26","conditions":"Pregnancy","enrollment":4700},{"nctId":"NCT06102863","phase":"PHASE2","title":"Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2023-04-01","conditions":"Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","enrollment":38},{"nctId":"NCT06162611","phase":"PHASE4","title":"Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo","status":"RECRUITING","sponsor":"Lori Gawron","startDate":"2023-11-06","conditions":"Emergency Contraception","enrollment":790},{"nctId":"NCT04750070","phase":"PHASE3","title":"Management of Shock in Children With SAM or Severe Underweight and Diarrhea","status":"RECRUITING","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2021-08-17","conditions":"Shock Hypovolemic, Shock, Septic, Blood Transfusion","enrollment":135},{"nctId":"NCT02146950","phase":"","title":"European Active Surveillance Study of LCS12","status":"ACTIVE_NOT_RECRUITING","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2014-06-17","conditions":"Contraception","enrollment":97265},{"nctId":"NCT02076217","phase":"","title":"Quick Start of Highly Effective Contraception","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2014-02","conditions":"IUD, Contraceptive Implant, Contraception","enrollment":1030},{"nctId":"NCT06500390","phase":"NA","title":"Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System","status":"RECRUITING","sponsor":"Marmara University","startDate":"2024-01-15","conditions":"Levonorgestrel Adverse Reaction, Temporomandibular Joint Disorders, Temporomandibular Disorder","enrollment":100},{"nctId":"NCT03660046","phase":"","title":"Contraceptive Hormones, Immunity, and Microbiome Evaluation","status":"COMPLETED","sponsor":"Emory University","startDate":"2018-12-07","conditions":"Hormonal Contraception","enrollment":155},{"nctId":"NCT03751800","phase":"","title":"A Study Run At Multiple Study Sites to Test Whether the SAMANTA Questionnaire That is Used to Diagnose Heavy Menstrual Bleeding (HMB), Can Also Be Used to Assess Changes of Severity of HMB in Women with HMB Who Are Treated During 12 Months with a Chronic Hormonal Treatment","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-12-12","conditions":"Menorrhagia","enrollment":422},{"nctId":"NCT06620939","phase":"NA","title":"The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence","status":"NOT_YET_RECRUITING","sponsor":"Zhang Jian","startDate":"2024-12-01","conditions":"Endometrial Polyp","enrollment":558},{"nctId":"NCT03241888","phase":"PHASE2, PHASE3","title":"Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia","status":"COMPLETED","sponsor":"Fudan University","startDate":"2017-07-04","conditions":"Atypical Endometrial Hyperplasia","enrollment":180},{"nctId":"NCT01686126","phase":"PHASE2","title":"Improving the Treatment for Women With Early Stage Cancer of the Uterus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Queensland Centre for Gynaecological Cancer","startDate":"2012-12","conditions":"Complex Endometrial Hyperplasia With Atypia, Grade 1 Endometrial Endometrioid Adenocarcinoma","enrollment":165},{"nctId":"NCT00995150","phase":"PHASE3","title":"A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception","status":"TERMINATED","sponsor":"Medicines360","startDate":"2009-11","conditions":"Contraception","enrollment":1910},{"nctId":"NCT04983771","phase":"","title":"Validity of Experts and ScanNav Anatomy PNB When Identifying Sono-anatomical Structures for Ultrasound-Guided Regional Anaesthesia","status":"COMPLETED","sponsor":"IntelligentUltrasound Limited","startDate":"2021-09-01","conditions":"Ultrasound Imaging of Anatomical Structures","enrollment":19},{"nctId":"NCT06468215","phase":"NA","title":"Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-07","conditions":"Carcinoma, Endometrioid, Fertility Preservation","enrollment":16},{"nctId":"NCT06478992","phase":"NA","title":"Hysteroscopic Suture Fixation of Mirena in the Treatment of Adenomyosis","status":"NOT_YET_RECRUITING","sponsor":"First People's Hospital of Hangzhou","startDate":"2024-06-30","conditions":"Adenomyosis, Hysteroscopy","enrollment":144},{"nctId":"NCT06304220","phase":"NA","title":"Comparison of Two PPOS Models for Pituitary Suppression","status":"NOT_YET_RECRUITING","sponsor":"NextFertility","startDate":"2024-07","conditions":"Infertility, Female, Fertility Disorders","enrollment":210},{"nctId":"NCT06391502","phase":"NA","title":"Vivifrail Program on the Degree of Debilitation in Hospitalized Patients After Venous Hemolysis in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Affiliated Hospital of Nantong University","startDate":"2024-08-01","conditions":"Ischemic Stroke, Exercise Therapy, Frailty","enrollment":2},{"nctId":"NCT01539720","phase":"NA","title":"Levonorgestrel Intrauterine System For Emergency Contraception","status":"COMPLETED","sponsor":"Planned Parenthood of the St. Louis Region and Southwest Missouri","startDate":"2012-12","conditions":"Pregnancy, Unplanned, Pregnancy; Accident","enrollment":274},{"nctId":"NCT01721798","phase":"NA","title":"Comparison of Two Intrauterine Devices (IUDs) Among Cape Town HIV-positive Women","status":"COMPLETED","sponsor":"FHI 360","startDate":"2013-11-10","conditions":"HIV","enrollment":199},{"nctId":"NCT03493295","phase":"","title":"Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding Pattern","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-04-25","conditions":"Contraception","enrollment":587},{"nctId":"NCT02477202","phase":"NA","title":"Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-06","conditions":"Epithelial Ovarian Cancer","enrollment":7},{"nctId":"NCT01961375","phase":"","title":"MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study: MIDAS Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-10-30","conditions":"Contraception","enrollment":600},{"nctId":"NCT04814927","phase":"PHASE4","title":"Impact of Contraceptives on Cervico-Vaginal Mucosa","status":"COMPLETED","sponsor":"Eastern Virginia Medical School","startDate":"2021-03-01","conditions":"Mucosal Inflammation, Contraceptive; Complications, Intrauterine","enrollment":112},{"nctId":"NCT05986344","phase":"","title":"Uterine Artery Doppler and Menstrual Changes After Insertion Intrauterine Contraceptive Device","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-08-30","conditions":"Intrauterine Contraceptive Device Complication","enrollment":165},{"nctId":"NCT05945407","phase":"NA","title":"Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2016-08-01","conditions":"Endometrial Neoplasms, Endometrial Neoplasm Malignant, Endometrial Neoplasm Malignant Stage I","enrollment":57},{"nctId":"NCT03074045","phase":"PHASE3","title":"LCS16 vs. COC User Satisfaction and Tolerability Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-03-13","conditions":"Contraception","enrollment":145},{"nctId":"NCT02863445","phase":"PHASE4","title":"Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2017-07-06","conditions":"Obesity","enrollment":70},{"nctId":"NCT03657602","phase":"EARLY_PHASE1","title":"Immediate Postpartum Insertion of Contraceptive Intrauterine Devices","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2019-12-15","conditions":"Contraception","enrollment":28},{"nctId":"NCT03462758","phase":"NA","title":"Early vs. Interval Postpartum IUD Insertion","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2018-03-20","conditions":"Contraception","enrollment":404},{"nctId":"NCT00635362","phase":"NA","title":"Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2007-05","conditions":"Healthy","enrollment":42},{"nctId":"NCT05742503","phase":"","title":"Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level","status":"COMPLETED","sponsor":"Tanta University","startDate":"2021-03-30","conditions":"Progesterone, Contraceptive Methods","enrollment":80},{"nctId":"NCT00653159","phase":"PHASE4","title":"Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2007-07","conditions":"Contraception","enrollment":23},{"nctId":"NCT02349815","phase":"","title":"JAYDESS Drug Utilization Study in Sweden","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-01-01","conditions":"Contraception","enrollment":10000},{"nctId":"NCT05565573","phase":"PHASE2, PHASE3","title":"Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients","status":"UNKNOWN","sponsor":"Hua Li","startDate":"2022-11-01","conditions":"Fertility Sparing","enrollment":148},{"nctId":"NCT05492487","phase":"PHASE2","title":"A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore","status":"UNKNOWN","sponsor":"KK Women's and Children's Hospital","startDate":"2020-01-03","conditions":"Endometrial Hyperplasia, Fertility Issues, Disease Regression","enrollment":60},{"nctId":"NCT02175030","phase":"PHASE4","title":"RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC","status":"COMPLETED","sponsor":"University of Utah","startDate":"2016-08","conditions":"Contraception","enrollment":711},{"nctId":"NCT02985541","phase":"PHASE3","title":"Mirena Extension Trial","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-12-22","conditions":"Contraception","enrollment":364},{"nctId":"NCT01873170","phase":"","title":"Quantification of Immune Cells in Women Using Contraception (CHIC II)","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2013-08","conditions":"HIV, Immune Cells (Mucosal and Systemic), Contraception","enrollment":326},{"nctId":"NCT01230242","phase":"NA","title":"Postplacental Mirena IUD Insertion and Estimating Expulsion Rates.","status":"TERMINATED","sponsor":"Rebecca Hunt","startDate":"2010-09-07","conditions":"Estimating Rates of Expulsion","enrollment":4},{"nctId":"NCT03317795","phase":"PHASE4","title":"Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids","status":"COMPLETED","sponsor":"Shannon K. Laughlin-Tommaso","startDate":"2017-11-14","conditions":"Heavy Menstrual Bleeding, Menorrhagia, Uterine Fibroids","enrollment":18},{"nctId":"NCT03463252","phase":"PHASE2, PHASE3","title":"Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC","status":"RECRUITING","sponsor":"West China Second University Hospital","startDate":"2018-04-01","conditions":"Endometrial Cancer, Atypical Endometrial Hyperplasia","enrollment":224},{"nctId":"NCT04872244","phase":"NA","title":"Can Intrauterine Levonorgestrel Releasing Device Be a Treatment Option for Postmenstrual Spotting in Isthmocele","status":"COMPLETED","sponsor":"Gaziosmanpasa Research and Education Hospital","startDate":"2019-11-03","conditions":"Isthmocele, Post-menstrual Spotting Bleeding, Pelvic Pain","enrollment":30},{"nctId":"NCT02002260","phase":"NA","title":"Stopping Heavy Periods Project","status":"UNKNOWN","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2013-02","conditions":"Abnormal Uterine Bleeding, Abnormal Uterine Bleeding, Ovulatory Dysfunction, Abnormal Uterine Bleeding, Endometrial Hemostatic Dysfunction","enrollment":59},{"nctId":"NCT03182140","phase":"","title":"KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-07-06","conditions":"Contraception","enrollment":1134},{"nctId":"NCT03428854","phase":"","title":"Adenomyosis: Genomic Mechanisms and Biological Response","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2020-12-01","conditions":"Adenomyosis, Abnormal Uterine Bleeding","enrollment":""},{"nctId":"NCT02475356","phase":"","title":"Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-08-04","conditions":"Menorrhagia, Dysmenorrhea","enrollment":601},{"nctId":"NCT04646161","phase":"","title":"Prostaglandins Use Before Mirena IUD Insertion in Prev CS Women During Lactational Amenorrhea","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-11-25","conditions":"to Study the Estimate Difficulty of Insertion Mirena IUD With Use of Prostaglandins","enrollment":400},{"nctId":"NCT03754556","phase":"","title":"Study on Medical Records of Women Using an Intrauterine Device (IUD) to Analyze the Risks That the IUD Will be Expelled or Perforates the Womb in Relation to Breastfeeding, the Point in Time When the IUD Was Inserted After Childbirth and in Relation to Different Types of IUDs","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-12-03","conditions":"Intrauterine Devices","enrollment":326658},{"nctId":"NCT03992937","phase":"NA","title":"Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2019-06-20","conditions":"Endometrial Hyperplasia Without Atypia","enrollment":132},{"nctId":"NCT03241914","phase":"PHASE2, PHASE3","title":"Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer","status":"COMPLETED","sponsor":"Fudan University","startDate":"2017-07-04","conditions":"Endometrial Neoplasm Malignant Stage I","enrollment":64},{"nctId":"NCT02357368","phase":"PHASE4","title":"Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk","status":"COMPLETED","sponsor":"Lisa Haddad","startDate":"2015-02","conditions":"HIV, Contraception","enrollment":59},{"nctId":"NCT01805817","phase":"PHASE4","title":"Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality","status":"WITHDRAWN","sponsor":"Istanbul Training and Research Hospital","startDate":"2012-12","conditions":"Contraceptive Methods Comparison","enrollment":""},{"nctId":"NCT03353857","phase":"PHASE1","title":"Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-11-29","conditions":"Biological Availability","enrollment":68},{"nctId":"NCT03499379","phase":"","title":"Stress Hormones and IUDs","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2018-04-16","conditions":"Contraception, Mood Change","enrollment":39},{"nctId":"NCT00445887","phase":"PHASE2","title":"Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer","status":"COMPLETED","sponsor":"Gynecologic Oncology Group","startDate":"2008-03-10","conditions":"Ovarian Carcinoma","enrollment":60},{"nctId":"NCT02735551","phase":"PHASE4","title":"LARC Forward Contraceptive Counseling at MHCC","status":"TERMINATED","sponsor":"Oregon Health and Science University","startDate":"2016-04","conditions":"Contraception","enrollment":3},{"nctId":"NCT03562624","phase":"PHASE2","title":"A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-06-22","conditions":"Contraception","enrollment":177},{"nctId":"NCT02067663","phase":"","title":"Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-04","conditions":"Contraception","enrollment":123},{"nctId":"NCT02490774","phase":"PHASE2","title":"To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development","status":"TERMINATED","sponsor":"Bayer","startDate":"2015-06-22","conditions":"Contraception","enrollment":174},{"nctId":"NCT02169869","phase":"NA","title":"Immediate Postplacental IUD Insertion","status":"TERMINATED","sponsor":"Oregon Health and Science University","startDate":"2014-09","conditions":"Contraception","enrollment":33},{"nctId":"NCT02104609","phase":"","title":"Effects of Obesity on Pharmacokinetics of the Levonorgestrel Emergency Contraceptive Pill","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2013-04","conditions":"Obesity","enrollment":26},{"nctId":"NCT01074892","phase":"PHASE4","title":"A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia","status":"COMPLETED","sponsor":"University Hospital of North Norway","startDate":"2005-05","conditions":"Endometrial Hyperplasia","enrollment":170},{"nctId":"NCT01755715","phase":"NA","title":"Immediate Versus Later Insertion of IUD After Medical Termination of Pregnancy","status":"COMPLETED","sponsor":"Riina Korjamo","startDate":"2013-01","conditions":"Contraception After Medical Abortion","enrollment":264},{"nctId":"NCT01594476","phase":"PHASE4","title":"Early Postpartum Intrauterine Device (IUD) Placement","status":"TERMINATED","sponsor":"Oregon Health and Science University","startDate":"2012-03","conditions":"Contraception","enrollment":201},{"nctId":"NCT01598662","phase":"NA","title":"Safety and Expulsion of Delayed Versus Immediate Postpartum Intrauterine Device Placement","status":"TERMINATED","sponsor":"University of Louisville","startDate":"2009-07","conditions":"Contraception","enrollment":32},{"nctId":"NCT02740998","phase":"","title":"Long-Acting Progestin Contraception and the Vaginal Microbiome","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2016-03","conditions":"Sexually Transmitted Infection","enrollment":28},{"nctId":"NCT02934789","phase":"NA","title":"Effectiveness of Truclear on Patient Quality of Life","status":"COMPLETED","sponsor":"All For Women Healthcare, Illinois","startDate":"2014-09","conditions":"Heavy Menstrual Bleeding","enrollment":69},{"nctId":"NCT02846142","phase":"PHASE1","title":"Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers","status":"COMPLETED","sponsor":"Proteostasis Therapeutics, Inc.","startDate":"2016-06","conditions":"Healthy Volunteer","enrollment":94},{"nctId":"NCT03186586","phase":"PHASE4","title":"Ulipristal Versus Placebo for Women With Bleeding Induced by Mirena","status":"UNKNOWN","sponsor":"University of Campinas, Brazil","startDate":"2017-07-01","conditions":"Heavy Menstrual Bleeding, Abnormal Bleeding","enrollment":32},{"nctId":"NCT01299116","phase":"PHASE4","title":"Long-Acting Reversible Contraception","status":"COMPLETED","sponsor":"FHI 360","startDate":"2011-12","conditions":"Contraception","enrollment":916},{"nctId":"NCT03074903","phase":"","title":"Does Skyla Insertion Timing Impact Bleeding?","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2016-04-16","conditions":"Vaginal Bleeding","enrollment":132},{"nctId":"NCT02903888","phase":"","title":"A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-09-08","conditions":"Intrauterine Devices, Medicated","enrollment":886},{"nctId":"NCT01240811","phase":"NA","title":"Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for Contraception","status":"COMPLETED","sponsor":"Sharon Achilles","startDate":"2010-11","conditions":"Genital Tract Mucosal Immunity, Genital Tract Microflora","enrollment":42},{"nctId":"NCT01272960","phase":"NA","title":"Mirena Intrauterine System Timing of Insertion: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2010-10","conditions":"Postpartum Period","enrollment":53},{"nctId":"NCT01601366","phase":"PHASE2","title":"LNG-IUS for Treatment of Dysmenorrhea","status":"COMPLETED","sponsor":"Omar Mamdouh Shaaban","startDate":"2012-04","conditions":"Adenomyosis","enrollment":62}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Plan B (Levonorgestrel)","genericName":"Plan B (Levonorgestrel)","companyName":"University of Pennsylvania","companyId":"university-of-pennsylvania","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levonorgestrel is a synthetic progestin that prevents pregnancy primarily by inhibiting or delaying ovulation. Used for Emergency contraception to prevent pregnancy following unprotected intercourse or contraceptive failure.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}